HIV Protease Substrate 1 is a fluorogenic compound that offers insights into the enzymatic activity of HIV protease, making it a valuable tool for studying this aspect.
(Cys47)-HIV-1 tat Protein (47-57) possesses membrane translocation functionality and can serve as a surface derivatization agent for magnetic pharmaceuticals, thereby enhancing their uptake into specific target cells.
HIV gag peptide (197-205) is an H-2Kd-restricted epitope derived from the p24 portion of the HIV-1 gag protein, composed of amino acids 197-205 (AMQMLKETI).
HIV p17 Gag (77-85) is an attractive target for molecular intervention due to its role in the viral replication cycle at both pre- and postintegration levels. In current experiments, we targeted p17 by intracellularly expressing a cDNA encoding [compound].
MPG, a 27-amino acid peptide compound, is derived from the fusion peptide domain of HIV-1 gp41 and the nuclear localisation sequence of SV40 large T antigen. As a potent delivery agent, MPG enables efficient and widespread transport of nucleic acids and oligonucleotides into cultured cells.